The President's Leadership Council

Karin Shanahan


Karin Shanahan Headshot

Karin began her career in the pharmaceutical industry at Bristol-Myers Squibb in their corporate global procurement organization. She quickly moved from procurement into global supply chain where she focused on enhancing business processes such as the Product Development and Commercialization (PD&C) process. Following an assignment with global quality, Karin moved into manufacturing operations, leading two manufacturing sites, first a radiopharmaceutical site in Billerica, MA and then a Chemical and Drug Product manufacturing site Latina, Italy. After returning to the U.S., she left BMS to join Becton-Dickenson leading global operations in Pre-Analytical Services, followed by Catalent Pharmaceuticals where she led their global Biologics operations. In 2013 she joined Teva Pharmaceuticals, where she led a network of 25 sites in Canada, US, Latin America and Europe; later as COO, Global Operations she led network strategy and global manufacturing science & technology. Prior to rejoining Bristol Myers Squibb earlier this year, she held the role SVP, Global Biologics & Sterile Operations at Merck & Co. for 4 years, where she had end to end supply chain responsibility for biologics, including Keytruda and a growing biologics pipeline.

In her current role, EVP, Global Product Development & Supply, Karin is a member of the BMS executive committee reporting directly to Chris Boerner. In this role she has responsibility for product development, quality, supply chain, manufacturing operations (biologics, small molecule and cell therapy), global engineering, and business analytics.

She has enjoyed growing in her career while also building a family with her husband, Tim. Together they enjoy three daughters (Amber, Sarah and Kathryn) and their dog, Tucker.

She graduated from Rutgers University with her BA in Political Science, International Relations, and holds a Masters in Pharmaceutical & Device Law from Seton Hall University.